Dipna Pharmachem Ltd — Important, 21-01-2026: Company Update

Dipna Pharmachem has secured trading approval from BSE for 2.24 Cr new equity shares. These shares were issued to non-promoter investors through a preferential allotment following the conversion of previously issued warrants. Each share has a face value of Rs. 10, allotted at a premium of Rs. 3.05. This trading approval signifies that these new shares are now officially listed and available for public trading on the exchange. This move expands the company's equity base and enhances liquidity for the investors who converted their warrants into shares.